KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Receivables (2016 - 2026)

Bausch Health Companies' Receivables history spans 18 years, with the latest figure at $2.2 billion for Q1 2026.

  • On a quarterly basis, Receivables rose 5.74% to $2.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.2 billion, a 5.74% increase, with the full-year FY2025 number at $2.4 billion, up 1532.64% from a year prior.
  • Receivables hit $2.2 billion in Q1 2026 for Bausch Health Companies, down from $2.4 billion in the prior quarter.
  • Over the last five years, Receivables for BHC hit a ceiling of $2.4 billion in Q3 2025 and a floor of $144.0 million in Q4 2024.
  • Historically, Receivables has averaged $1.9 billion across 5 years, with a median of $2.0 billion in 2023.
  • Biggest five-year swings in Receivables: plummeted 92.79% in 2024 and later skyrocketed 1532.64% in 2025.
  • Tracing BHC's Receivables over 5 years: stood at $1.8 billion in 2022, then increased by 11.62% to $2.0 billion in 2023, then plummeted by 92.79% to $144.0 million in 2024, then skyrocketed by 1532.64% to $2.4 billion in 2025, then fell by 6.81% to $2.2 billion in 2026.
  • Business Quant data shows Receivables for BHC at $2.2 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.